Published in Dermatology on January 09, 2008
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. Br J Dermatol (2015) 1.42
Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence? Case Rep Dermatol (2011) 1.09
Concise review of recent studies in vitiligo. Qatar Med J (2013) 0.88
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One (2012) 0.87
Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open (2016) 0.81
Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response? Ann Dermatol (2015) 0.75
Evaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. ISRN Dermatol (2014) 0.75
Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes. Int J Biol Sci (2017) 0.75
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis Rheum (2009) 3.58
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis (2011) 2.61
The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol (2002) 1.55
Prevalence of rheumatic regional pain syndromes in adults from Mexico: a community survey using COPCORD for screening and syndrome-specific diagnostic criteria. J Rheumatol Suppl (2011) 1.46
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis (2013) 1.39
Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl (2011) 1.30
Diagnosis of chronic gout: evaluating the american college of rheumatology proposal, European league against rheumatism recommendations, and clinical judgment. J Rheumatol (2010) 1.16
Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum (2008) 1.04
A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2006) 1.00
Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol (2011) 1.00
[Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective]. Gac Med Mex (2008) 0.93
Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatol Clin (2012) 0.92
Metabolic syndrome and ischemic heart disease in gout. J Clin Rheumatol (2004) 0.89
Epidemiology of rheumatic diseases. A community-based study in urban and rural populations in the state of Nuevo Leon, Mexico. J Rheumatol Suppl (2011) 0.86
The diagnostic value of the proposal for clinical gout diagnosis (CGD). Clin Rheumatol (2011) 0.86
Association of regional and cultural factors with the prevalence of rheumatoid arthritis in the Mexican population: a multilevel analysis. J Clin Rheumatol (2015) 0.86
Validity of the COPCORD core questionnaire as a classification tool for rheumatic diseases. J Rheumatol Suppl (2011) 0.85
A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans. J Clin Rheumatol (2013) 0.85
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol (2006) 0.84
Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol (2004) 0.84
Primary prevention in rheumatology: the importance of hyperuricemia. Best Pract Res Clin Rheumatol (2004) 0.83
In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis. J Rheumatol (2012) 0.81
Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial. J Rheumatol (2012) 0.81
[Complementary and alternative medicine in patients attending a rheumatology department for the first time. Analysis of 800 patients]. Reumatol Clin (2008) 0.81
Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study. Clin Rheumatol (2011) 0.80
Towards elucidation of the epidemiology of the rheumatic diseases in Mexico. COPCORD studies in the community. J Rheumatol Suppl (2011) 0.79
[Diagnosis and treatment of gout in Mexico City. Results from a physicians survey]. Rev Invest Clin (2004) 0.79
Very recent onset arthritis: the value of initial rheumatologist evaluation and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Rheumatol (2009) 0.79
[Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)]. Rev Invest Clin (2009) 0.78
CD4 and CD8 T cell response to the rHSP60 from Klebsiella pneumoniae in peripheral blood mononuclear cells from patients with ankylosing spondylitis. Rev Invest Clin (2005) 0.78
'Not-belonging': illness narratives of Mexican patients with ankylosing spondylitis. Med Anthropol (2013) 0.77
Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin. Medicine (Baltimore) (2016) 0.76
A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article. Medicine (Baltimore) (2015) 0.75
Predictors of response to tumor necrosis factor-alpha blockers in ankylosing spondylitis. J Rheumatol (2005) 0.75
Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort. Medicine (Baltimore) (2016) 0.75
Usage problems and social barriers faced by persons with a wheelchair and other aids. Qualitative study from the ergonomics perspective in persons disabled by rheumatoid arthritis and other conditions. Reumatol Clin (2012) 0.75
[Identification of the best sites for the histopathological study of tarsitis in patients with spondyloarthropathies]. Reumatol Clin (2008) 0.75
The use of glucocorticoids by rheumatologic patients before attending a specialized department in México. J Clin Rheumatol (2008) 0.75